| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccd9173f2aabd93562c916f9a2dbff4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8637f539b76997d280cbc646d68ca713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_772f02e6ee0415abf4810c1a2d599e80 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a99a8ccc172cb3c948b7e1f747a854f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f141d0c8cd61620b0eb4111e84f2ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb2de654d806af98031f55f0fc90141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5665ded1765ae58c7e171661eaa682cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8482bf74bcd9acc2cc5b2f010e6a211 |
| publicationDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2674167-A1 |
| titleOfInvention |
Controlled activation of complement components for use as endogenous adjuvant |
| abstract |
The invention relates to a pharmaceutical composition made of one or more preparation and comprising a therapeutically effective dose of at least one recombinant human C3-derivative and at least one antigen for vaccination. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3711748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680107-B2 |
| priorityDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |